Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-30

FDA Approved: ZERVIATE — Original Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved ZERVIATE (cetirizine ophthalmic solution) via its original application by Harrow Eye, LLC for the treatment of allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZERVIATE (Cetirizine)

Snippet

ORIG AP for ZERVIATE (CETIRIZINE)